Beyond Pass/Fail: Why SAPs Rely on Quantitative Data and MRO Notes

By Nicole Hanratty, CEAP, SAP, SAE, C-DERT; COO at ASAP, Inc.

In the world of DOT regulated drug testing, the MRO and the SAP represent two distinct but deeply interconnected pillars of public safety. While the MRO determines the “what” of a drug test result, the SAP must determine the “why” and “what’s next.”

To provide an accurate assessment, SAPs frequently request quantitative drug test levels and MRO interview notes. This isn’t just a request for more paperwork: It is a vital step in ensuring clinical accuracy and maintaining public safety. Here is why both quantitative and qualitative data points are essential to the SAP evaluation process.

Validating the Narrative

A primary challenge SAPs face is employees’ tendencies to minimize their substance use. Employees commonly claim “one-time use” or an accidental exposure. Quantitative drug test levels provide an objective benchmark to validate these claims. If an employee’s account of a single use contradicts high quantitative levels, the SAP can identify a potential pattern of habitual use that requires more intensive treatment than an education program.

Additionally, MRO interview notes often capture the employee’s initial explanation, which may differ significantly from the story told to the SAP. Identifying these inconsistencies early prevents “red flags” from surfacing midway through a treatment program, which could force an employee to begin again at a higher level of care.

Clinical Precision and Treatment Planning

A positive test result alone doesn’t tell the full story. Quantitative levels provide helpful context, but insight from the MRO allows the SAP to validate details, clarify circumstances, and make a more informed, accurate assessment. This is critical for:

• Substance Confirmation: Confirming if multiple substances were present when an employee only admits to using one.
• Test Context: Verifying if the test was truly a “random” or a “reasonable suspicion” positive, which provides context about the employee’s behavior on the job.
• Severity Assessment: Higher concentrations often indicate a need for intensive outpatient or inpatient care rather than basic drug education.

Adding Certainty & Removing Stress from the Return to Duty Process

For substances like THC, which remain in the system for longer periods, quantitative levels help SAPs estimate clearance timelines. By understanding the exact initial concentration, a SAP can better guide the employee on when to attempt a Return to Duty (RTD) test.

This consideration helps prevent employees from bearing the frustration and cost of premature lab-based testing. Instead, the SAP can direct them toward more affordable over-the-counter test kits until levels of THC (or other long-lasting substances) decline enough to support a negative non-DOT, independent lab test prior to the follow-up SAP evaluation. This approach reduces the risk of a RTD positive caused by residual presence, which in some DOT regulated modes could permanently disqualify the employee from working in that role again.

For Providers: Added Defensibility and Compliance

Leveraging all available information, including insights from the MRO, strengthens the SAP’s ability to support and defend their clinical recommendations. While this level of detail can be helpful during an audit, its primary value lies in demonstrating that the SAP conducted a thorough, well-informed assessment rather than relying solely on the employee’s own report. Incorporating objective data adds depth and credibility to the evaluation and reflects a more thoughtful clinical judgment.

Ultimately, this level of collaboration between the MRO and the SAP ensures that the RTD process is not just a checkbox, but a sound clinical decision that prioritizes public safety.

---

To learn more about ASAP, Inc. and our fully vetted SAP network for RTD referrals, contact info@go2asap.com or call 888-792-2727.

Visit our website: https://go2asap.com/